Literature DB >> 16613944

Inquiry into adverse events in trial blames drug, not study design.

Susan Mayor.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16613944      PMCID： PMC1440637          DOI： 10.1136/bmj.332.7546.870-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Severe adverse reactions prompt call for trial design changes.

Authors:  Susan Mayor
Journal:  BMJ       Date:  2006-03-25
  1 in total
  3 in total

1.  After the London tragedy, is it still possible to consider Phase I is safe?

Authors:  Michel Sibille; Yves Donazzolo; Franck Lecoz; Emmanuel Krupka
Journal:  Br J Clin Pharmacol       Date:  2006-07-03       Impact factor: 4.335

2.  Textbook of Pharmaceutical Medicine warns of trial risks.

Authors:  Chek C Chan
Journal:  BMJ       Date:  2006-04-29

3.  Should we tolerate tolerability as an objective in early drug development?

Authors:  A Cohen
Journal:  Br J Clin Pharmacol       Date:  2007-09       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.